ABC Medical Center > Estudios Laboratorio > BCR/ABL1 TYROSINE KINASE RESIS INHIBITOR

BCR/ABL1 TYROSINE KINASE RESIS INHIBITOR

Evaluation of patients with chronic myelogenous leukemia and Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia receiving treatment with tyrosine kinase inhibitors (TKIs), who are apparently failing treatment.
Preferred initial test to identify the presence of acquired BCR-ABL1 mutations associated with TKI resistance.

How can we help you?